IL34 and ovarian carcinoma: Our data confirm and expand on results from previous studies showing that JQ1 inhibits IL-34 expression in the murine ovarian cancer cell lines OV3121-RAS4 and HM-1, and this effect was not due to changes in cell viability [17,18].